ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)].
Abstract readConsensus Statement
In one paragraph
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis.Frontiers in oncology · 2021Pooled it
- [Application Effect of Fast Track Surgery for Patients with Lung Cancer: A Meta-analysis].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2016Pooled it
- Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective study.American journal of cancer research · 2026Article
- International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.Translational lung cancer research · 2023Review
- Anlotinib combined with gefitinib can significantly improve the proliferation of epidermal growth factor receptor-mutant advanced non-small cell lung cancerTranslational lung cancer research · 2021Article
- Gene Targets Network Analysis for the Revealing and Guidance of Molecular Driving Mechanism of Lung Cancer.Frontiers in genetics · 2021Article
- Treatment patterns, clinical outcomes, and healthcare resource use associated with advanced/metastatic lung cancer in China: protocol for a retrospective observational study.Translational lung cancer research · 2020Article
- Associations of MTA1 expression with CT features, pathology and prognosis of elderly patients with non-small cell lung cancer.Oncology letters · 2020Article
- The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.BMC cancer · 2020Article
- Concordance of Treatment Recommendations for Metastatic Non-Small-Cell Lung Cancer Between Watson for Oncology System and Medical Team.Cancer management and research · 2020Article
- The expression of the circadian gene TIMELESS in non-small-cell lung cancer and its clinical significance.International journal of clinical and experimental pathology · 2020Article
- [MRTF-A Regulates the Proliferation and Migration of Non-small Cell Lung Cancer Cells of A549 through HOTAIR].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019Article
- Effects ofBioscience reports · 2019Article
- [Molecular Imaging in vivo Detection of EGFR Mutations in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Review
- [Current Status and Prospect of T790M Mutation in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Review
- [Advances in the Treatment of Relapsed Small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Review
- [Efficacy and Potential Application of Neoadjuvant Chemotherapy in Patients with IIIa Stage Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
- [China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
- [China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
49 authors.
Yuankai ShiCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Yan SunCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Jinming YuShandong Province Cancer Hospital, Ji'nan 250117, China.
Cuimin DingThe Fourth Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Ziping WangBeijing Cancer Hospital, Beijing 100142, China.
Changli WangTianjin Medical University Cancer Institute & Hospital, Tianjin 300070, China.
Dong WangDaping Hospital, Third Military Medical University, Chongqing 400042, China.
Cunde WangYunnan Province Cancer Hospital, Kunming 650118, China.
Zheng WangBeijing Hospital, Beijing 100730, China.
Mengzhao WangPeking Union Medical College Hospital, Beijing 100730, China.
Xiuyi ZhiBeijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
You LuWest China Hospital of Sichuan University, Chengdu 610041, China.
Jifeng FengJiangsu Cancer Hospital, Nanjing 210009, China.
Yunpeng LiuThe First Hospital of China Medical University, Shenyang 110001, China.
Xiaoqing LiuThe 307th Hospital of Chinese People's Liberation Army, Beijing 100071, China.
Wei LiuBeijing Cancer Hospital, Beijing 100142, China.
Gang WuHuazhong University of Science and Technology Union Hospital, Wuhan 430022, China.
Xiaomei LiChinese People's Liberation Army General Hospital, Beijing 100853, China.
Kai LiTianjin Medical University Cancer Institute & Hospital, Tianjin 300070, China.
Enxiao LiThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Wei LiThe First Hospital of Jilin University, Changchun 130021, China.
Gongyan ChenHarbin Medical University Cancer Hospital, Harbin 150081, China.
Zhengtang ChenXinqiao Hospital of The Third Military Medical University, Chongqing 400037, China.
Ping YuSichuan Cancer Hospital, Chengdu 610047, China.
Ning WuCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Milu WuQinghai University Affiliated Hospital, Xining 810000, China.
Wenhua XiaoThe First Affiliated Hospital of Chinese People's Liberation Army General Hospital, Beijing 100048, China.
Li ZhangPeking Union Medical College Hospital, Beijing 100730, China.
Yiping ZhangZhejiang Cancer Hospital, Hangzhou 310022, China.
Shucai ZhangBeijing Chest Hospital, Capital Medical University, Beijing 101149, China.
Shujun YangHenan Province Cancer Hospital, Zhengzhou 450008, China.
Xia SongShanxi Province Cancer Hospital, Taiyuan 030013, China.
Dongmei LinBeijing Cancer Hospital, Beijing 100142, China.
Rongcheng LuoNanfang Hospital, Nanfang Medical University, Guangzhou 510515, China.
Li ShanCancer Hospital of Xinjiang Medical University, Urumqi 830000, China.
Caicun ZhouShanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China.
Zongmei ZhouCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Qiong ZhaoThe First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China.
Chengping HuXiangya Hospital, Central South University, Changsha 410008, China.
Yi HuChinese People's Liberation Army General Hospital, Beijing 100853, China.
Qisen GuoShandong Province Cancer Hospital, Ji'nan 250117, China.
Jianhua ChangCancer Hospital, Fudan Universitay, Shanghai 200032, China.
Cheng HuangFujian Cancer Hospital, Fuzhou 350014, China.
Xuan ZengPeking Union Medical College Hospital, Beijing 100730, China.
Baohui HanShanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
Xiaohong HanCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Bo JiaCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Ying HanCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Yu HuangCancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsChinaConsensusHumansLung NeoplasmsRadiotherapyAntineoplastic Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.